Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Frontiers in Pharmacology
|
November 29, 2023
Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
Nadezhda A German
Current Topics in Medicinal Chemistry
|
September 25, 2021
Update on Modulators of Quorum Sensing Pathways in Pseudomonas aeruginosa
Mohammad Anwar Hossain, Nadezhda A German
Angiogenesis
|
November 8, 2017
Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions
Sanaullah Sajib, Fatema Tuz Zahra, Michail S Lionakis, et al.
Cancers
|
May 21, 2020
Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview
Md Ashraf-Uz-Zaman, Aditya Bhalerao, Constantinos M Mikelis, et al.
Frontiers in Microbiology
|
October 10, 2024
Exploring diflunisal as a synergistic agent against <i>Staphylococcus aureus</i> biofilm formation
Maria Salazar, Siavash Shahbazi Nia, Nadezhda A German, et al.
ACS Medicinal Chemistry Letters
|
April 8, 2014
Truncated Orexin Peptides: Structure-Activity Relationship Studies
Nadezhda A German, Ann M Decker, Brian P Gilmour, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 4, 2018
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity
Md Ashraf-Uz-Zaman, Md Sanaullah Sajib, Luca Cucullo, et al.
European Journal of Medicinal Chemistry
|
November 11, 2019
Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence
Mohammad Anwar Hossain, Narsimha Sattenapally, Hardik I Parikh, et al.
Journal of Medicinal Chemistry
|
August 15, 2013
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A Perrey, Nadezhda A German, Brian P Gilmour, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 29, 2021
Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects
Taslim A Al-Hilal, Mohammad Anwar Hossain, Ahmed Alobaida, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Frontiers in Pharmacology
|
November 29, 2023
Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
Nadezhda A German
Current Topics in Medicinal Chemistry
|
September 25, 2021
Update on Modulators of Quorum Sensing Pathways in Pseudomonas aeruginosa
Mohammad Anwar Hossain, Nadezhda A German
Angiogenesis
|
November 8, 2017
Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions
Sanaullah Sajib, Fatema Tuz Zahra, Michail S Lionakis, et al.
Cancers
|
May 21, 2020
Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview
Md Ashraf-Uz-Zaman, Aditya Bhalerao, Constantinos M Mikelis, et al.
Frontiers in Microbiology
|
October 10, 2024
Exploring diflunisal as a synergistic agent against <i>Staphylococcus aureus</i> biofilm formation
Maria Salazar, Siavash Shahbazi Nia, Nadezhda A German, et al.
ACS Medicinal Chemistry Letters
|
April 8, 2014
Truncated Orexin Peptides: Structure-Activity Relationship Studies
Nadezhda A German, Ann M Decker, Brian P Gilmour, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 4, 2018
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity
Md Ashraf-Uz-Zaman, Md Sanaullah Sajib, Luca Cucullo, et al.
European Journal of Medicinal Chemistry
|
November 11, 2019
Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence
Mohammad Anwar Hossain, Narsimha Sattenapally, Hardik I Parikh, et al.
Journal of Medicinal Chemistry
|
August 15, 2013
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A Perrey, Nadezhda A German, Brian P Gilmour, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 29, 2021
Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects
Taslim A Al-Hilal, Mohammad Anwar Hossain, Ahmed Alobaida, et al.
Page
of 2